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Calmodulin (CaM) binds in a Ca2-dependent manner to the
intracellular C-terminal domains of most group III metabo-
tropic glutamate receptors (mGluRs). Here we combined muta-
tional and biophysical approaches to define the structural basis
of CaM binding to mGluR 7A. Ca2/CaM was found to interact
with mGluR 7A primarily via its C-lobe at a 1:1 CaM:C-tail stoi-
chiometry. Pulldown experiments with mutant CaM and
mGluR 7AC-tail constructs and high resolutionNMRwith pep-
tides corresponding to the CaM binding region of mGluR 7A
allowed us to define hydrophobic and ionic interactions
required for Ca2/CaM binding and identified a 1-8-14 CaM-
binding motif. The Ca2/CaMmGluR 7A peptide complex dis-
plays a classical wraparound structure that closely resembles
that formed byCa2/CaMuponbinding to smoothmusclemyo-
sin light chain kinase. Our data provide insight into how Ca2/
CaM regulates group III mGluR signaling via competition with
intracellular proteins for receptor-binding sites.
G-protein-coupled metabotropic glutamate receptors
(mGluRs)7 have been implicated in the regulation of transmit-
ter release, short and long term modulation of synaptic trans-
mission, neuronal development, and synaptic plasticity (1–4).
mGluRs are structurally distinct from family A and BG-protein
coupled receptors, as they possess a large extracellular ligand
binding domain and a comparatively long intracellular C termi-
nus (3, 5). At least eight different mGluR isoforms have been
identified and classified into three subgroups based on
sequence homology, downstream effectors, and agonist speci-
ficity. Group III mGluRs (mGluR 4 and 6–8) are specifically
activated by L-amino()-2-amino-4-phosphonobutyric acid,
negatively coupled to adenylate cyclase and, apart frommGluR
6, are exclusively located presynaptically. Coupling to other sig-
nal transduction pathways may occur in some tissues; for
mGluR 7, inhibition of P/Q-type calcium channels involving
phospholipase C has been demonstrated in cerebellar granule
cells (6). With the exception of mGluR 6, which is exclusively
found in the retina, group IIImGluRs are expressed throughout
the brain. The most abundant family member, mGluR 7, dis-
plays a low affinity for glutamate, is highly enriched at transmit-
ter release sites (7), and is thought to act as a lowpass filter at the
axon terminal by inhibiting synaptic transmission upon high
frequency stimulation.Mice lackingmGluR 7 exhibit increased
seizure susceptibility (8), suggesting that this receptormay play
a role in epileptogenesis (9). Furthermore, recent genetic asso-
ciation studies implicatemGluR 7 in psychiatric disorders, such
as bipolar depression (10).
Different lines of evidence indicate that signal transduction
by group III mGluRs is highly regulated intracellularly (5, 11).
First, mGluRs 7 and 8 exist in different splice variants A and B
that differ in the C-terminal sequences of their cytoplasmic tail
regions. Second, the C-tails of group III mGluRs have been
found to interact with various cytoskeleton-associated and
Ca2-regulated proteins (5, 11). In particular, all group III
mGluRs except mGluR 6 display Ca2-dependent calmodulin
(CaM) binding to a conserved binding motif located in the
N-terminal regions of their C-tails (12). A cluster of positively
charged amino acids and a conserved serine residue (Ser862)
precede a hydrophobic motif containing the actual CaM-bind-
ing sequence. Based on binding experiments and sequence
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alignment, we tentatively proposed a 1–5-10 CaM-binding
motif for the C terminus of mGluR 7 (13, 14). Mutational anal-
ysis of the CaM-bindingmotif revealed that it overlaps with the
interaction site for G-protein -subunits (G) (12), suggest-
ing that Ca2/CaM may regulate signal transduction of the
receptor. Consistent with this view, we found that CaM antag-
onists abrogate glutamatergic autoinhibition in autaptic hip-
pocampal neurons and prevent the mGluR 7A-triggered acti-
vation of inwardly rectifying potassium channels co-expressed
in HEK 293 cells (15). However, Sorensen et al. (16) reported
that Ca2/CaM is not required for G-mediated G-protein-
coupled inwardly rectifying potassium channel activation, as
signaling appeared unaffectedwithmutant receptors that failed
to bind Ca2/CaM in vitro. Thus, the physiological role of
Ca2/CaM binding to mGluR 7A is presently controversial.
However, the stringent conservation of the CaM-bindingmotif
in group III mGluRs strongly argues for an important function
of this interaction.
CaM includes large N- and C-terminal globular domains,
each including a pair ofCa2-binding EFhandmotifs, EFs 1 and
2 in theN terminus andEFs 3 and 4 in theC terminus (17). Ca2
ions bind to CaM in a highly cooperative manner, first to EFs 4
and 3 and subsequently to EFs 2 and 1. Ca2 binding to CaM
induces conformational rearrangements resulting in exposure
of a hydrophobic pocket in each domain. Both pockets are
capable of accommodating a large hydrophobic amino acid
such as tryptophan, phenylalanine, and leucine. Target pep-
tides adopt -helical structures or, less commonly, -hairpin-
like loops to achieve an arrangement of key hydrophobic resi-
dues that allows binding within the two CaM pockets. As a
result, the two domains of CaM effectively wrap around the
target peptide; this is facilitated by a highly flexible inter-do-
main linker that connects the globular Ca2 binding domains.
Substitutions of the Ca2-coordinating residues reduce the
Ca2 binding affinity of the EF hands by 10–1000-fold and
abolish the characteristic Ca2-induced conformational
change of CaM domains (18).
Recent reports (19–21) have identified novel patterns of
CaM binding to target sequences that unraveled functional dif-
ferences between the two CaM lobes. Thus, CaM actions may
extend over a wide spectrum, from classical binding with or
without pre-association to cross-linking of two different target
molecules (22). To further clarify the mode of CaM binding to
group III mGluRs that are known to function as homodimers
(23), we performed a detailed mutational and NMR analysis of
the mGluR 7A C-tail-Ca2/CaM interaction. The results pre-
sented here show that mGluR 7A and Ca2/CaM form a clas-
sical wraparound CaMreceptor complex with a 1:1 stoichiom-
etry and a basic 1-8-14 receptor-binding motif similar to that
found in smoothmuscle myosin light chain kinase. In addition,
our structural data indicate that Ca2/CaM binding to mGluR
7A includes interactions with both Ser862, a target site for phos-
phorylation by protein kinase C (13, 24, 25), and the G rec-
ognition motif, and thus support the view that CaM regulates
signal transduction in an activity-dependent manner by com-
petition for receptor-binding sites (15).
EXPERIMENTAL PROCEDURES
Expression Constructs—Glutathione S-transferase (GST)
fusions of the C-terminal tail region of mGluR 7A (GST-7A-C)
and of different tail mutants have been described previously
(12) (see also Fig. 2). GFP fusion constructs of mGluR 7A-C
were generated by subcloning the C-terminal domain into
pEGFP-C2 (Clontech). Rattus norvegicus CaM wild type and
mutant cDNA inserts were generated by PCR from rat brain
cDNAorCaMcDNA, kindly donated by J. P. Adelman (26), and
inserted into the pEGFP-C3 vector (Clontech) using SacI and
KpnI sites. The cDNA encompassing the complete coding
sequence of the rat calmodulin 1 gene was amplified from rat
brain cDNA. Oligonucleotides corresponding to the 5 and 3
ends of the calmodulin cDNA with flanking BamHI and SalI
restriction sites, respectively, were as follows: 5-AGGGATC-
CTGAATGGCTGACCAACTGACTG-3 and 5-GTGTG-
GACTCACTTCGCTGTCATCATTTG-3. Expand high fidel-
ity (Roche Applied Science) was used in accordance with
manufacturer’s instruction using 2 min at 72 °C followed by 30
amplification cycles (30 s, 94 °C; 30 s, 56 °C; 30 s, 72 °C) and a
final extension period of 10 min (72 °C). The flanking BamHI
and SalI sites were used to clone the resulting cDNA into the
pQE3 vector (Qiagen), and the resulting CAM1pQE3 plasmid
was amplified inXL-1 blue cells (Stratagene, La Jolla, CA). After
confirmatory DNA sequencing of the CAM1 insert in both
directions, the resulting CAM1pQE3 plasmid was used for
expression of untagged calmodulin; translation was driven
from the authentic ATG that had been engineered directly
adjacent to an artificial 5 stop codon (TGA).
Protein Expression and Binding Studies—Expression of GST
fusion proteins was performed in Escherichia coli BL21 DE3
(Stratagene) as described (12). HEK 293 T cells expressing GFP
or GFP-7A-C (for gel filtration) and wild type or mutant GFP-
CaM (for pulldown assays) were first lysed mechanically in a
glass douncer in 25 mM Tris-Cl, pH 7.4, containing 100 mM
NaCl, and then agitated for 1 h at 4 °C with 1.5% (w/v) Triton
X-100. For pulldown assays, the detergent extracts were centri-
fuged at 45,000  g and 4 °C for 45 min. Then 500 l of the
supernatant were incubated with 30 l of glutathione-Sepha-
rose beads (GE Healthcare) pre-loaded with GST-7A-C in 25
mMTris-Cl, pH7.4, containing 100mMNaCl and 300MCaCl2
or 5mM EGTA, respectively. After 2 h of rotary agitation, beads
were collected by centrifugation and washed three times with
binding buffer containing CaCl2 or EGTA as above. After elu-
tion with SDS sample buffer, the eluate fractions were resolved
on a 10%SDS-polyacrylamide gel, followed byWestern blotting
with polyclonal rabbit anti-GFP (Clontech).
Determination of Molecular Size Using Gel Filtration—Su-
pernatants of HEK detergent extracts were directly used for gel
filtration experiments. Proteinswere separated on a pre-packed
Superose 12 PC 3.2/30 column using a Smart system (GE
Healthcare). The running buffer was 25 mM Tris-Cl, 100 mM
NaCl, pH 7.4; 300 M CaCl2 or 5 mM EGTA was added as indi-
cated. The column was calibrated by using blue dextran for
exclusion volume determination or 50 l of a mixture of pro-
teins of known size (chymotrypsinogen, ovalbumin, and albu-
min; Bio-Rad). Protein elution was monitored by absorption at
CaMBinding tomGluR 7A
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280 nm or Western blot analysis of eluate fractions. GFP or
GFP-tagged proteins were visualized at their absorption maxi-
mum (488 nm) using a Peak monitor with a wavelength accu-
racy of 2 nm and a spectral bandwidth of 4 nm. Elution curves
were evaluated using the Smart Manager software (GE
Healthcare).
Isothermal Titration Calorimetry—Isothermal titration cal-
orimetry (ITC) was performed at 32 °C on a Microcal VP-ITC
calorimeter (Microcal, Northampton, MA). CaM and peptide
were prepared and dialyzed in the same buffer (20 mM BisTris,
300 mM KCl, 6 mM CaCl2, pH 6.8). All samples were degassed
before use. In the syringe, the peptide concentration was 500
M, whereas the CaM concentration in the sample cell was 20
M. ITCmeasurements were performed with 18 injections of 6
l of peptide solution into the cell containing CaM while stir-
ring at 310 rpm. Heats of dilution were corrected using the last
titration points, and data were analyzed using the Wiseman
isotherm for a one-site binding model as implemented in the
Microcal Origin software.
NMR Sample Preparation—For protein expression, the
CAM1pQE3 vector was transformed into E. coli BL21 DE3
(Stratagene) and initially screened for protein expression using
isopropyl 1-thio--D-galactopyranoside induction (1 mM) in
1-ml mini-cultures (Qiagen). Uniformly labeled recombinant
CaM was overexpressed in E. coli (BL21 DE3) grown solely on
M9 media supplemented with 1 g/liter 15NH4Cl and 2 g/liter
13C6-D-glucose. Prior to induction, the cultures were incubated
at 37 °C before being cooled to 30 °C and subsequent incuba-
tion with isopropyl 1-thio--D-galactopyranoside for 18 h.
Cells were harvested after 18 h, and labeledCaMwas purified to
homogeneity (27) using phenyl-Sepharose chromatography.
Peptides corresponding to the mGluR 7 CaM binding region
were synthesized using standard solid phase technology (Pep-
tide Protein Research, Fareham, UK). NMR samples were pre-
pared as 1mMCaM in 20mMBisTris, 300mMKCl, 6mMCaCl2,
pH 6.8, 0.05%NaN3 in 600l of 5%D2O inH2O for assignment
purposes. Such samples were diluted with the aforementioned
buffer to half the original CaMconcentration for relaxation and
residual dipolar coupling (RDC) measurements. The molar
ratio of peptide to CaM used was 1.1:1. Aligned samples were
prepared by adding a pre-dried 600-l volume, 5mmdiameter,
5% polyacrylamide gel to a 600-l 0.5 mM CaM sample and
allowing the gel to swell for 48 h at 4 °C prior to insertion into a
5-mm NMR tube and data collection. Peptides corresponding
to themGluR 7A, residues 856–875, 856–875 phosphorylated
at Ser-862 and Ser-856–879,mGluR 7A-(856–875), Ser(P)862-
mGluR 7A-(856–875), and mGluR 7A-(856–879), respec-
tively, were purchased from Protein Peptide Synthesis (Peptide
Protein Research, Fareham, UK).
NMR Measurements—All NMR experiments were recorded
on a Varian Inova 600-MHz spectrometer at 32 °C. Backbone
assignments of Ca2/CaM and the peptide complexes thereof
were achieved using three-dimensional HNCACB (28, 29) and
CBCACONH (30) experiments. Chemical shift perturbations
() of the [1H]-15N spectra with and without ligand were calcu-
lated using combined 1H and 15N chemical shifts () as shown
in Equation 1,
  1H2 13615N2 (Eq. 1)
The dissociation constant of the Ser(P)862-mGluR 7A-(856–
875)Ca2/CaM complex was determined by chemical shift
titration. Two 0.1 mM samples of CaMwere prepared in 20 mM
BisTris, 300 mM KCl, 6 mM CaCl2, 0.05% NaN3, pH 6.8. One
sample was supplemented with Ser(P)862-mGluR 7A-(856–
875) to 2 mM (20:1 ratio), and the pH adjusted to 6.8. [1H]-15N
HSQC spectra were recorded on each of these samples before
aliquots of peptide sample were added to the CaM only sample
to achieve peptide to protein ratios of 0:0, 0.5:1, 1:1, 2:1, 4:1, 8:1,
and 12:1. The combined 1H and 15N chemical shifts of residues
in fast exchange were analyzed using y [X]/(KD [X]), where
y is the fractional shift; [X] is the peptide concentration, andKD
is the dissociation constant.
The dependence of RDCs on the relative orientations of the
amide bonds provides powerful constraints on the solutions
structure ofmolecules. Here, RDCswere used to investigate the
solution structures of the CaM domains in the complexes and
their relative orientation (31). Provided a structure of a domain
is known, the RDCs define an alignment tensor that is charac-
terized by axial and rhombic components Aa and Ar, respec-
tively, indicating the strength of the alignment of a domain as
well as three rotation angles (Euler angles , , and ) that give
the orientation of the tensor with respect to the molecular
frame of the domain. By comparing alignment tensors of one
domain to the other one can define the overall structure of the
domains and in favorable cases get an indication of interdomain
dynamics. In a compact well structured state the two domains
of CaM are described by a common molecular frame, and con-
sequently the axial and rhombic components Aa and Ar of the
domains are expected to be within experimental error. By
the same token, the interdomain orientation in solution of
the complex in question is determined by rotating the
molecular frames of the N- and C-terminal domains such
that the alignment tensors of the individual domains are co-
linear. NMR data recorded on aligned samples revealed negli-
gible chemical shift changes when compared with the isotropic
data indicating the effects of the gelmatrix on the protein struc-
ture to be minimal. [1H]-15N dipolar couplings were recorded
using 0.5 mM Ca2/CaM, mGluR 7A-(856–875):Ca2/CaM,
and mGluR 7A-(856–879):Ca2/CaM samples with a 1.1:1
stoichiometry and were measured from two-dimensional
IPAP-type sensitivity-enhanced experiments (32), which had
been recorded with an acquisition time of 152 ms in the nitro-
gen dimension. Errors in the RDCswere estimated to be 0.5Hz.
In the mGluR 7A-(856–875)Ca2/CaM complex, 31 and 37
RDCs were determined, whereas in the mGluR 7A-(856–
879)Ca2/CaM complex, 57 and 52 RDCs were resolved in the
N- and C-terminal calmodulin domains, respectively. The
agreement between the data and the structures was evaluated
using a quality factor Q as shown in Equation 2 (33).
Q  rdcmeasured  rdccalculated2rdcmeasured2 (Eq. 2)
Comparisons of the RDC data were restricted to x-ray struc-
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tures of moderate to good resolution in the Protein Data Base.
15N relaxation time constants were calculated from a series of
seven two-dimensional 15N T1 and T2 relaxation spectra (34,
35) recorded with relaxation delays of 0.02, 0.08, 0.16, 0.32, 0.6,
1, and 1.5 s and 0.01, 0.03, 0.05, 0.07, 0.09, 0.13, and 0.15 s forT1
and T2, respectively. Data were processed with mild resolution
enhancement and zero filling in the proton dimension and linear
prediction in nitrogen. All data were processed using NMRPipe
andNMRDraw(36) andanalyzedusingNMRview(37).Rotational
correlation times were calculated from the average T1:T2 ratio of
residues in secondary structural elements only.
Molecular Modeling and Structure Refinement—Mutations
introduced into the R. norvegicus CaM and peptide sequences
weremodeled using Pymol (DeLano Scientific, San Carlos, CA)
based on the backbone coordinates of the high resolution struc-
ture of CaM complexed with the CaM binding region from
smooth muscle myosin light chain kinase (smMLCK, PDB
entry 1qtx). Alignment tensors were calculated for each CaM
domain (N-domain including residues 1–75 and C-domain
including residues 76–148) from [1H]-15NRDCdata in second-
ary structural elements using the programModule (38). For the
calculation, 57 and 52 RDCs were used in the N- and C-termi-
nal domains, respectively. The resulting alignment tensors of
the N- and C-terminal domains were rotated into a common
coordinate frame by rigid body rotation of the C-terminal
domain. The relative orientation of the domains was then fixed,
and the C-domain was translated to optimize the inter-domain
docking of helices 2 and 6 observed in the smMLCKCaM com-
plex. The inter-domain linker was allowed to break between
residues 75 and 76 to achieve this. The resulting structure was
annealed using the constant valence force fieldCVFF (39) in the
Discovermodule of InsightII (Accelrys Software Inc). Backbone
atoms of residues 1–73 and 78–148 and all atoms of Ca2-
coordinating residueswere fixed during the annealing protocol.
CaM mGluR 7A interactions were defined using a upper dis-
tance criterion of 4 Å.
RESULTS
Mutation of the Ca2-binding Sites in the C-terminal Lobe of
CaM Impairs mGluR 7A-C Binding—To analyze the contribu-
tions of the N- and C-terminal lobes of CaM to mGluR 7A
binding, we generated GFP-tagged constructs encoding CaM
carrying previously characterized point mutations of the Ca2
coordinating residues in its four EF-hands (26, 40). The ability
of the mutant and wild type CaM to bind GST-7A-C was then
examined by using a pulldown assay. Aspartate was mutated to
alanine either in the N-terminal (CaM 1,2), C-terminal (CaM
3,4) or both EF-hand pairs (CaM 1–4), the latter resulting in a
Ca2-insensitive CaM (20, 41) (Fig. 1). Wild type CaM and
CaM 1,2 were found to effectively bind GST-7A-C in a Ca2-
dependentmanner, whereas CaM1–4 did not detectably inter-
act. Compared with wild type CaM, binding of GFP-CaM 3,4
was significantly reduced. Thus, the two lobes of CaM contrib-
ute differently to Ca2-dependent mGluR 7A-C binding.
Binding of Endogenous Ca2/CaM Causes a Size Shift of
GFP-7A-C—Metabotropic glutamate receptors are known to
function as dimers (23), although previous fluorimetric studies
with dansylated CaM have indicated a 1:1 stoichiometry of the
mGluR 7A-C-Ca2/CaM interaction (12). As the data pre-
sented above revealed only a minor contribution of the N-lobe
of CaM to mGluR 7A binding, we wondered whether this
region of CaM could serve as a binding site for a second target
molecule, resulting in 1:2 CaM:target or 2:2 CaM:target stoi-
chiometries, as described for other CaM interactors (reviewed
in Ref. 22). We therefore performed gel filtration experiments
on a calibrated Sepharose PC12 column. In initial experiments,
we determined the size of complexes formed by recombinant
GST-7A-C and purified bovine brain CaM. An interaction was
detectable in the presence of 300 M Ca2, but the stoichiom-
etry could not be reliably evaluated, as both interaction partners
ran as homodimers (data not shown). To overcome this limita-
tion, we employed GFP-7A-C fusion proteins expressed in
mammalian cells, which could be readily detected in cell lysates
at the maximum excitation wavelength of GFP (488 nm) (Fig.
2). In addition, absorbance measurements at 488 nmwere con-
firmed by Western blotting with an anti-GFP antibody (data
not shown).
The elution patterns of GFP-7A-C and the truncated version
GFP-7A-N38 (Fig. 2E) are presented in Fig. 2. Both proteins
contain theCa2/CaMbinding domain (12) andwere tested for
differences in elution positions in the presence of either 300M
Ca2 or 5 mM EGTA. Both GFP-7A-C (Fig. 2A) and GFP-7A-
N38 (Fig. 2B) ran as narrow peaks in the presence of EGTA and
as wider asymmetrical peaks in the presence of Ca2, respec-
tively. Notably, the EGTA peaks in Fig. 2Bwere eluted at a later
volume as compared with Fig. 2A, consistent with the deletion
of 27 amino acids in the GFP-7A-N38 protein. In 300MCa2,
a size shift toward a lower elution volume was observed with
both proteins. This size shift was because of an interaction with
endogenousCa2/CaM, becauseGFP-7AF863A, amutant that
does not bind Ca2/CaM (12), eluted at identical positions
under both conditions (Fig. 2C). The only partial size shifts seen
in Fig. 2, A and B, in the presence of Ca2 presumably reflect
FIGURE 1. Ca2-binding sites in the C-terminal lobe of CaM are essential
forbinding tomGluR7A-C.Pulldownassays using immobilizedGST, orGST-
7A-C, are shown.HEK 293 T cell lysateswere tested for expressionofGFP-CaM
wild type andmutants (left) and incubatedwith theGST fusionproteins in the
presence of 300 M Ca2 or 5 mM EGTA, respectively (right). After washing,
bound proteins were eluted with SDS sample buffer and analyzed by 10%
SDS-PAGE andWesternblottingwith antibodydirected against GFP (top pan-
els) or GST (bottom panel; loading control). Note that only CaMwild type and
CaM 1,2, but not CaM 3,4 and CaM 1–4, bound efficiently to GST-7A-C.
CaMBinding tomGluR 7A
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saturation of the endogenous CaM by other interacting
proteins.
To quantify the size shifts depicted in Fig. 2, A and B, we
subtracted the elution profiles obtained in the presence of
EGTA from those in Ca2-containing buffer, yielding peaks
that represent only the fractions of theGFP fusion proteins that
altered positions (Fig. 2, A and B, dotted lines). When plotting
the respective elution positions against those of marker pro-
teins of knownmolecular weight, differences of about 19 and 20
kDa were found for GFP-7A-C and GFP-7A-N38 (Fig. 2D),
respectively. This value corresponds to the approximate pre-
dicted molecular size of CaM and confirms a 1:1 stoichiometry
of mGluR 7A-C binding to native Ca2/CaM.
Structural Analysis of the mGluR 7A-C CaM Interaction—
The binding region of mGluR 7A (comprising residues 860–
876) contains two pairs of hydrophobic residues with correct
spacing to bind CaM, suggesting that two different modes of
CaM binding could exist. The interaction of Ca2/CaM with
mGluR 7A-C was therefore investigated further using NMR
spectroscopy. To this end, two pep-
tides were synthesized comprising
the CaM binding region. They cor-
respond to residues 856–875 and
856–879 of mGluR 7A (Fig. 3A).
The shorter mGluR 7A-(856–875)
peptide is representative of a basic-
1–10 motif similar to that found in
CaM kinase II (42) and predicted
to utilize Phe863 andMet872 as bind-
ing residues for the exposed hydro-
phobic sites of Ca2/CaM. The
extended mGluR 7A-(856–879)
sequence represents a basic 1-8-14
motif similar to that found in
smooth muscle myosin light chain
kinase (43) and as such should dock
to Ca2/CaM using Phe863 and
Leu876. The mGluR 7A sequence is
unusual in that instead of a basic
residue a serine (Ser862) precedes
the phenylalanine, which is the site
of phosphorylation by protein
kinase C (13, 24). Phosphorylation
at equivalent sites in other binding
sequences has been shown to
greatly reduce the affinity for Ca2/
CaM. The dissociation constant of
mGluR 7A-(856–875)Ca2/CaM
complex was determined by ITC to
be 100 nM with a 1:1 stoichiometry
(supplemental Fig. S1). This dissoci-
ation constant dropped by about
1000-fold when the mGluR
7A-(856–875) peptide was phos-
phorylated at Ser862 (supplemental
Fig. S2).
Incubation of both mGluR 7A-
(856–875) and mGluR 7A-(856–
879) with Ca2/CaM at peptide to protein ratios of 1.1:1 com-
pletely converted free CaM to the complexed form, as observed
by their 1H amide and 15N chemical shifts. Changes in amide
chemical shift upon complex formation withmGluR 7A-(856–
875) and mGluR 7A-(856–879) are shown in Fig. 3, B and C,
respectively. The data clearly show that both peptides affect the
structure of the N- and C-lobes of CaM. A number of signals
from residues in the central linker of CaM in the mGluR
7A-(856–875)Ca2/CaM complex were too broad to be
observed in NMR spectra. The reappearance of these peaks in
the mGluR 7A-(856–879)Ca2/CaM spectra together with
modest chemical shift changes as compared with the free state
suggests that the linker is stabilized upon binding of the
extended peptide. The modest chemical shift differences
between the mGluR 7A-(856–875) and mGluR 7A-(856–879)
complexes (Fig. 3D) indicate similarity between the structures
of the two peptide protein complexes. Moreover, they pro-
vide insight into the orientation of the peptide with respect
to the two CaM domains. The largest chemical shift differ-
FIGURE 2.Analysis by gel filtration of Ca2/CaMbinding tomGluR 7A-C.GFP-7A-C shows a size shift in the
presence of Ca2. Overlay of elution curves of GFP-7A-C (A) or GFP-7A-N38 (B) obtained in 5mM EGTA and 300
MCa2, respectively, is displayed as detected at 488 nm. Note that the elution profiles obtained in Ca2 show
shoulders. Subtraction of both curves (dotted lines in A and B) illustrates the fraction of GFP fusion protein that
underwent a size shift toward a higher molecular weight. C shows that GFP-7A F863A, a mutant known not to
bind Ca2/CaM, does not undergo a size shift in the presence of Ca2. D shows a plot of the elution peak
volumes determined in A-C at 488 nm (in ml; filled squares) together with the elution volumes of proteins of
knownmolecular weight (monitored at 280 nm; open squares). E, sequence ofmGluR 7A-C (residues 851–915).
The mGluR-N38 truncation used in B is indicated above the sequence. The CaM binding region is underlined.
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ences between the two peptideCa2/CaM complexes are
seen in the C-lobe. These only occur in helix 5, which is
adjacent to the interdomain linker and the C terminus,
whereas otherwise the chemical shift differences in the two
complexes in this lobe are very small. In contrast, the N-lobe
is more globally altered upon extension of the peptide with
the exclusion of helix 1 (Fig. 3D). This suggests that the
C-terminal extension of mGluR 7A-(856–879) is located
near helix 5 and the interdomain linker of CaM. In this ori-
entation the observations of differences in helix 2 and 3 of
the N-terminal CaM lobe for the extended peptide are con-
sistent with a wraparound CaM structure (see below).
Rotational correlation times (	c) of CaM were determined
using 15N relaxation measurements and used to characterize
interdomain dynamics. The N- and C-lobes had correlation
times of 7.1 0.1 and 6.5 0.1 ns, respectively, which is in good
agreement with the literature values of 7.1 and 6.3 ns of similar
calmodulin peptide complexes (44). Dynamics analysis of the
truncated determinant mGluR 7A-(856–875)Ca2/CaM
complex revealed a narrowing in the range of T1s and T2s, con-
sistent with a reduction in the plasticity of the CaM domains.
The correlation times formGluR 7A-(856–875)Ca2/CaMN-
and C-lobes were determined to be 7.1 0.1 and 7.2 0.1 ns,
respectively, indicating that the two domains now tumble at
similar rates. This information, coupled with the 1:1 peptide:
CaM stoichiometry, indicates that the mGluR 7A-(856–
875)Ca2/CaM complex adopts the classical wraparound
structure common to most CaMpeptide complexes (43, 45,
46). Similarly, 	c values calculated for the N- and C-lobes in the
mGluR 7A-(856–879)Ca2/CaM complex were 7.9 0.1 and
7.8  0.1 ns, respectively. These values are in good agreement
with the correlation time of 7.6 ns that was recorded for com-
parable peptide complexes, such as the 26-mer olfactory CNG
channel fragmentCaM complex (47) when considering that
those data were collected at 35 °C rather than at 32 °C as used
here.
Further insight into the nature of the interaction between the
CaMand themGluR 7A-C peptides was obtained bymeasuring
1H-15N RDCs for both the mGluR 7A-(856–875)Ca2/CaM
and mGluR 7A-(856–879)Ca2/CaM complexes (Fig. 4). It
can be seen in Fig. 4, A and B, that good correlations of meas-
ured and calculatedRDCswere found for both complexeswhen
the RDCs were calculated using the CaM domain from
smMLCK (PDB entry 1qtx) in complex with the RS20 peptide.
Differences in the strength of the alignment of individual
domains as reflected by differences in the values for the axial
and rhombic components of the alignment tensorsAa andAr of
the individual domains are qualitative indicators of interdo-
main motion. The largest difference in alignment of the N- and
C-lobes was found for the rhombic component of free CaM
(data not shown); this is consistent with the presence of inter-
lobe motion. In contrast, the differences in alignment and
domain orientation between the N- and C-lobes in the mGluR
7A-(856–879)Ca2/CaM complex are very small (Fig. 4D).
This is indicative of a compact globular structure. Overall the
alignment tensors of the lobes in the mGluR 7A-(856–
875)Ca2/CaM complex are similar but not quite as co-linear
as in the complex with the extended mGluR 7A sequence (Fig.
4C). Using the smMLCK:CaM coordinates as a model for the
mGluR 7A-(856–879)Ca2/CaM complex, helices 2 and 3 in
theN-lobe andhelix 5 of theC-lobe ofCaMare surrounding the
extra four residues of mGluR 7A-(856–879). This is consistent
FIGURE 3. Interaction of CaM with the mGluR 7A binding region. Amino
acid sequence of the peptides mGluR 7A-(856–875) and mGluR 7A-(856–
879) is shown;numbers above the sequence indicate position of hydrophobic
anchor residues (A). Chemical shift perturbation of CaM backbone amide
groups is shown in the presence of mGluR 7A-(856–875) (B) and mGluR
7A-(856–879) (C). Chemical shift differences between the Ca2/CaMmGluR
7A-(856–875) and Ca2/CaMmGluR 7A-(856–879) complexes are shown in
D.  is the chemical shift difference of the combined 1H and 15N shifts. The
positions of CaMhelices are indicatedbyblack bars andnumbered from theN
to the C terminus.
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with the chemical shift changes observed between the binding
of mGluR 7A-(856–875) and mGluR 7A-(856–879) (Fig. 3D),
as well as with the observed changes in the line shapes of the
preceding interdomain linker. The combined RDC and chemi-
cal shift data provide good evidence for a classic wraparound
structure of the Ca2/CaMmGluR 7A complex.
Residual dipolar couplings have been used successfully to
classify CaM-binding motifs present in the protein kinase fam-
ily (48) and,more recently, to evaluatemotifs outside the kinase
family (47). The latter proved to be successful only if the RDCs
used in the analysis were restricted to those residues located in
structured regions of CaM. The binding modes of the mGluR
7A peptides were tested by fitting the RDCs of the mGluR
7A-(856–875)Ca2/CaM and mGluR 7A-(856–879)Ca2/
CaM complexes to the coordinates of 13 CaMpeptide com-
plexes, including examples from the 1-8-14, 1-10, 1-16, and IQ
motifs and the peptide-free closed form of CaM (PDB entry
1prw) as well as more unusual binding modes, such as that of
the glutamate decarboxylaseCaM complex (PDB entry
1nwd) where two helical peptides were observed to bind
between the CaM domains. As a
result for each structure, one
obtains two alignment tensors
(one for each domain) together
with measures of the quality of the
fit. The results of fitting 13 struc-
tures to the RDC data were evalu-
ated using the quality of the agree-
ment between the structure and
the data as quantified by the qual-
ity factor Q, and the agreement
between the domain orientations of
the tested structures with the data
as shown by small domain rotations
(, , and ) required to obtain
co-linearity of the alignment ten-
sors of the CaM domains. The same
analysis was applied to RDCs of the
shorter mGluR 7A-(856–875)
Ca2/CaM (data not shown) and
extended mGluR 7A-(856–879)
Ca2/CaM complexes (Table 1).
The best (lowest)Q value and the
best fit of the alignment tensors for
both the mGluR 7A-(856–875)
Ca2/CaM and mGluR 7A-(856–
879)Ca2/CaM complexes were
obtained when the RDC data were
compared with the crystal structure
of smMLCK. This was surprising
FIGURE 4.Domain orientation of CaM/mGluR 7Abinding region complexes. Correlation and linear regres-
sion between measured dipolar couplings of mGluR 7A-(856–875)Ca2/CaM (A) and mGluR 7A-(856–
879)Ca2/CaM (B) are shown with back-calculated dipolar couplings using the N- and C-terminal domains of
the smMLCKpeptide complex (PDBentry 1qtx) individually, and ribbondiagramsof smMLCKpeptide complex
with alignment tensors for the N- and C-terminal domains of mGluR 7A-(856–875)Ca2/CaM (C) and mGluR
7A-(856–879)Ca2/CaM are shown in D. Data and ribbon representations corresponding to the N-terminal
domain, C-terminal domain and the peptide are in gold, green and cyan, respectively. Bound Ca2 atoms are
shown as black spheres. The figure was created using MolMol (57).
TABLE 1
Summary of alignment tensors for the CaMmGluR 7A856–879 complex
Structurea Binding motifb Qc d d d Aae Are 	2
f
1QTX (1.65 Å) Basic 1-8-14 0.29 6.7 1.7 5.7 0.18 0.11 298
1QS7 (1.8 Å) Basic 1-8-14 0.33 5.5 5.1 20.1 0.07 0.02 379
1MXE (1.7 Å) 1-14 0.33 3.4 3.0 12.0 0.21 0.02 387
1WRZ (2.0 Å) Basic 1-5-8-14 0.36 22.8 0.8 1.8 0.07 0.02 427
1NIW (2.0 Å) Basic 1-5-8-14 0.36 311.3 11.4 32.7 0.03 0.35 421
1CDL (2.0 Å) Basic 1-8-14 0.37 8.1 0.7 10.7 0.41 0.13 477
2F3Y (1.4 Å) 1-10 0.31 160.9 39.7 151.7 0.17 0.25 352
1CDM (2.0 Å) Basic 1-10 0.32 16.2 10.9 1.9 0.18 0.11 374
1IQ5 (1.8 Å) 1-16 0.30 22.2 30.4 1.4 0.08 0.03 320
1IWQ (2.0 Å) 1 hydrophobic 0.32 149.6 26.3 172.6 0.02 0.02 358
1L7Z (2.3 Å) NA 0.34 6.7 17.3 16.4 0.24 0.00 413
2F2O (2.2 Å) NA 0.51 149.0 7.6 168.6 0.14 0.11 891
1PRW (1.7 Å) No peptide 0.35 163.0 18.3 181.6 0.23 0.28 444
a PDB entry codes and resolution for structures that were tested are shown.
b Structures were classified according to their binding motifs as proposed in Ref. 50.
c The quality factor Qmeasures the agreement between the data and the structures.
d , , and  represent the difference in , , and  Euler angles, respectively, between the N- and C-domains of CaM in the mGluR 7A856–879Ca2/CaM complex.
e  and Ar denote the difference in the axially symmetric and rhombic components of the alignment tensors between N- and C-domains.
f 	
2
 values are the mean of the total 	
2
 values for the N- and C-domains of CaM in the mGluR 7A856–879Ca2/CaM complex.
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because the smMLCK structure is
an example for a binding mode of a
basic 1-8-14 motif, whereas the
mGluR 7A-(856–875) peptide is
lacking the anchor residue leucine
(Leu876) at position 14. This sug-
gests that the second large hydro-
phobic residue is not required for
either complex formation or main-
tenance of structural integrity. This
is further supported by inspection of
the Q values and Euler angles of the
other structures that contain 1-14
or basic 1-8-14motifs. Themajority
of those structures fit the data for
the mGluR 7ACa2/CaM peptide
complexes well and generally better
than complexes with other motifs.
In our case, however, comparison of
Q values across structures repre-
senting different bindingmotifs was
not sufficient to determine the
binding mode, because the second
and third lowest Q values were
obtained with structures that have
either 1-16 (PDB entry 1iq5) or 1-10
(PDB entry 2f3y) motifs. Interest-
ingly, both of these structures
require significant domain reorien-
tations to agree with the solution
structures, as indicated by large val-
ues for either,, or in Table
1. This suggests that the fold of a
CaMpeptide complex may not be
dictated by the spacing of the
observed anchoring residues of the
peptide, because our RDC data,
when compared across a full range
of CaM structures, did not closely
match all structures of a certain
motif.
Modeling of the Interaction of
Ca2/CaM with mGluR 7A—To
further analyze the interaction
between mGluR 7A and the N- and
C-lobes of CaM, we modeled the
mGluR 7A-(856–879)Ca2/CaM
complex using the smMLCK CaM
structure as a template. This crystal
structure shows a collapsed CaM
conformation bound at a 1:1 stoi-
chiometry. Similar to the target
sequence in smMLCK, the CaM
binding region of mGluR 7A adopts
an -helical conformation, as evi-
denced from filter-editedNMRdata
collected on a sample of 13C, 15N-
CaM in complex with unlabeled
CaMBinding tomGluR 7A
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mGluR 7A-(856–875) peptide (data not shown). After rotating
the N- and C-terminal domains to satisfy the RDC data and
docking the mGluR 7A-(856–879) peptide in CaM according
to the positioning in the rotated smMLCK complex, the struc-
ture was energy-minimized. The resulting structure showed
good overall energies and no steric clashes. Fig. 5 shows a sur-
face representation of the resulting structural model. Accord-
ingly, anchor residues 1 (Phe863) and 5 (Val867) of themGluR7A
binding domain point into the hydrophobic pocket of the
C-lobe of CaM, whereas residues 10 (Met872) and 14 (Leu876)
are located in the pocket of the N-lobe (Fig. 5, A and B).
The following side chain interactions were predicted with
the C-lobe of CaM. Based on interatomic distances, the first
residue (Phe863) of the 1-8-14motif (Fig. 5C) is likely to interact
with a number of hydrophobic residues in the C-lobe of CaM
that form a hydrophobic pocket (Phe92, Leu105, Met124, Val136,
Phe141, Met144, and Met145). The central anchor residue
(Val867) is also located within the same hydrophobic pocket
(interactions to Phe92, Phe141, andMet145). Another hydropho-
bic residue is the preceding residue Val866 (Fig. 5C), which may
interact with the CaM residues Phe92, Val108, Met109, and
Leu112 and is located at position 4 of the CaM-bindingmotif. In
addition there are electrostatic interactions. The C-terminal
end of the peptide binding channel of CaM is known to have a
negatively charged rim, whereas the N-lobe is thought to pres-
ent clusters of negatively and positively charged residues (43,
45, 49). These surface charges contribute to peptide binding
via electrostatic interactions and are thought to determine
the relative orientation of the CaM binding domain peptides
on the C-lobe (50). In agreement with this idea, our model
suggests electrostatic interactions between Arg859 of mGluR
7A and CaM residues Glu123 and Glu127 and between Lys860
and residues Glu127 and the C-terminal carboxyl group of
CaM (Fig. 5C).
The model also predicts interactions with the N-lobe of
CaM: The hydrophobic residue Met872 of mGluR 7A points
toward the hydrophobic patch of the calmodulin N-lobe and
lies in close vicinity of CaM residues Phe19, Phe68, Met71, and
Met72 (Fig. 5C). An additional hydrophobic residue in position
14 (Leu876 of mGluR 7A) is predicted to interact with the
N-lobe, whereas in the CaM structure of smMLCK the apolar
residue Asn312 is located at this position (45). For both Asn312
and the following hydrophobic residue Phe313 of the smMLCK
CaM structure, no interaction with the N-lobe has been
reported. In contrast to previous studies (50), ionic interactions
between mGluR 7A and the charged rim of the N-lobe were
only found between negatively charged side chains of CaM and
basic residues of mGluR 7A (Fig. 5B). Arg861 of mGluR 7A is
predicted to interact with Glu7 and Glu14 of CaM. Ser862 is
within hydrogen bonding space of both Glu14 and Glu120 of
calmodulin. This serine is of particular interest as its phospho-
rylation reduces the binding constant of mGluR 7A-(856–875)
to CaM by about 1000-fold and abolishes CaM binding (13)
which, based on our model, would be explained by anionic
repulsion.
Binding Studies with Targeted mGlu7A-C Point Mutations
Corroborate the Modeling Predictions—Previous experiments
had already shown that binding to wild type CaM is abolished
upon mutation of the hydrophobic anchor residue 1 (F863A),
whereas substitution of residue 10 by alanine (M872A) did not
interfere with binding (12). Here we dissected the individual
contributions of the N- and C-lobes to mGluR 7A binding by
mutating hydrophobic (Phe863, Val867, Val868, Met872, and
Leu876) and charged (Arg859, Arg861) residues in GST-7A-C.
The binding properties of the resulting fusion proteins were
tested in pulldown assays with a panel of GFP-taggedCaMcon-
structs consisting of the wild type protein and the EF hand
mutants CaM 1,2, CaM 3,4, and CaM 1–4. Fig. 6 shows that
substitutions of all residues in GST-7A-C that interact with the
C-lobe impede binding to CaM proteins (Fig. 6, top half),
whereas mutations of residues interacting with the N-terminal
domain retained residual binding except in case of CaM 1–4
(Fig. 6, bottom half). This corroborates the notion that the
interaction of GST-7A-C with the C-lobe provides most of the
binding energy.
Themost profound reduction inCaMbindingwas seen upon
alanine substitution of the anchor residue Phe863 (position 1 in
the 1-8-14 motif of mGlu7A-C) which interacts with the
C-lobe. This mutation abrogated binding to both wild type and
mutantCaMs. Substitution ofVal867, the other large hydropho-
bic residue interacting with the C-terminal domain, impaired
binding to the CaM mutants but not significantly to the wild
type protein. The same result was obtained with the double
mutant V866A/V867A as well as the charge reversal substitu-
tion R859E, indicating that substitutions in C-lobe contacts are
critical once the “wraparound” configuration of CaM is dis-
turbed by mutations in the EF-hands. Conversely, N-lobe
anchor residue substitution did not abrogate mutant CaM
binding (Fig. 6, bottom panel). GST-7A-CL876A retained bind-
ing to both the N-terminal CaM 1,2 and C-terminal CaM 3,4
mutants but failed to detectably bind CaM 1–4. Individual side
chain contributions to the interaction of GST-7A-C with the
N-lobe of CaM were investigated by mutating Met872 to either
alanine or glutamic acid and by introducing a proline in lieu of
arginine Arg861 (Fig. 6, bottom half). M872A had no effect on
binding to any of the CaMmutants except CaM 1–4 and, judg-
ing by band intensity, may even increase binding to CaM 1,2. In
contrast, the M872E substitution reduced binding to all CaM
constructs, including wild type CaM. This is in line with the
uncharged nature of the side chains in CaM that lie close to
FIGURE 5. Model of CaM interaction with the CaM-binding site of mGluR 7A. The coordinates of the CaM homology model were used to calculate the
molecular surface of the N- and C-terminal domains of CaM. A, cross-section through the surface (colored by atom type with carbon in black, oxygen in red,
nitrogen in blue, and hydrogen in white), and mGluR 7A-(856–879) is depicted as a ribbon and stick representation colored similarly. B, model depicts the
charged rimofCaMand the interactionsmadewith theKRKR sequenceof themGluR7A-(856–879),which is coloredgreen for carbon for clarity. In both images
mGluR 7A-(856–879) and CaM residues are listed in italics and regular font, respectively. The displays were created usingMolMol (57). C, schematic diagramof
the predicted interactions betweenmGluR 7A-C and the Ca2/CaM complex. The line represents the-helical structure ofmGluR 7A-(856–879). The principal
interacting residues of the N- (top) and C-lobes (bottom) of CaM are boxed above and below themGluR 7A peptide sequence. Predicted side chain interactions
are indicated by dashes.
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Met872 (see above and Fig. 5C). Mutation R861P had the most
pronounced effect on CaM binding seen upon substitution of
residues that interact with the N-lobe. This is consistent with
this substitution both removing a long side-chain interaction
with the N-lobe interface and perturbing the helical nature of
the ligand. Taken together, the data highlight the importance of
Phe863 and reinforce the observation that the mGluR 7A binds
more strongly to theC-terminal domain than to theN-terminal
domain of CaM.
DISCUSSION
In this study, we investigated how Ca2/CaM interacts with
the cytoplasmic tail region of mGluR 7A, a low affinity G-pro-
tein-coupled glutamate receptor that mediates feedback inhi-
bition at presynaptic transmitter release sites (4, 5, 11).Our first
major result is that Ca2/CaM interacts with mGluR 7A-C pri-
marily via its C-lobe. The observation that CaM 1,2 still bound
tightly tomGluR 7A-Cmight indicate that this interaction rep-
resents another example of the “functional bipartition” of
Ca2/CaM action, which has been discovered in Paramecium
by Saimi and Kung (51). These authors found that mutations in
the N-lobe of CaM disrupted Ca2 activation of a potassium
channel, whereas mutations in the C-lobe abolished Ca2 acti-
vation of a sodium channel, thus revealing a potentially general
mechanism through which Ca2/CaM could enrich its signal-
ing repertoire. Some types of CaM-target interaction involve
“pre-binding” by one of the lobes in the absence of Ca2 or at
very low Ca2 concentrations, a process that accelerates Ca2/
CaM actions triggered by rises in cytosolic Ca2 levels. Such
mechanism could be particularly important in presynaptic ter-
minals, where Ca2 influx triggered in the millisecond time
range plays a crucial role in rapidly regulating neurotransmitter
release and synaptic vesicle recycling (52).
Second, we employed a GFP-7A-C fusion protein to re-ex-
amine the stoichiometry of CaM binding by gel filtration. This
approach clearly distinguishes 1:1 from higher order stoichio-
metries and allows the analysis of CaM-target complexes in
protein extracts from mammalian cells as compared to studies
with bacterial fusion proteins (53). Here, gel filtration of
extracts prepared fromGFP fusion protein-expressing cells did
not show any size shifts larger than 20 kDa, suggesting that in
our experiments onlyCa2/CaMwas recruited from the pool of
endogenous proteins. Also, in 5 mM EGTA all mGluR 7A-C
protein migrated as a homogeneous peak of38 kDa, consist-
ent with the interaction being strictly Ca2-dependent. These
results corroborate a 1:1 stoichiometry of the mGluR 7A-C-
Ca2/CaM interaction using proteins expressed inmammalian
cell extracts. Based on our results, a simultaneous interaction of
Ca2/CaM with both C-tails of the dimeric receptor can be
excluded.
Third, we employed high resolution NMR to define the
molecular nature of the interaction between CaM and mGluR
7A using two peptides comprising residues Val856–Arg875 and
Val856–Lys879 of the receptor’s CaM binding region. Both pep-
tides bound with high affinity to CaM. Comparison of the pep-
tide-induced chemical shift perturbations of CaM allowed to
define the orientation of the peptides within the Ca2/
CaMpeptide complexes. The tumbling times of the individual
domains in peptide-free and -bound CaM are consistent with a
transition from an open to a closed CaM conformation. We
examined the domain orientations of the CaM lobes in the pep-
tide-bound state and found that CaM binds mGluR 7A in a
wraparound structure, and that the binding region of mGluR
7A corresponds to a 1-8-14 CaM-binding motif.
By combining mutational analysis and molecular modeling,
we have also been able to identify several mGluR 7A-C residues
that are critical for CaM recognition. Based on our structural
data, a homology model of the CaM-mGluR 7A binding peptide
complex was built using the smMLCK-CaM complex as tem-
plate. The importance of residues predicted to be required for
Ca2/CaM binding was tested by binding assays with mutated
GST-7A-C constructs. First, the three hydrophobic anchor res-
idues ofmGluR7A-C that interactwith theC-lobe ofCaMwere
examined. Phe863, a side chain positioned deeply in the hydro-
phobic pouch, was found to be essential for Ca2/CaMbinding.
The presence of Phe863 appeared to be sufficient for binding of
wild type CaM, because binding still occurred when the neigh-
boring hydrophobic residue Val867 or both Val866/Val867 were
mutated. The same mutants failed to bind CaM 1,2; apparently
the Ca2-induced conformational change of the N-lobe has to
“lock” the bound helix. Notably, whereas the sequences of
mGluR 7 andmGluR 8 are identical throughout the CaM-bind-
ing motif, in mGluR 4 a leucine is found at the position of the
FIGURE 6.Mutations of hydrophobic anchor residues in mGluR 7A-C dif-
ferentially affect CaM binding. Different GST-7A-C constructs carrying
point mutations of charged and hydrophobic (labeled with asterisks) anchor
residues were used in pulldown assays with GFP-tagged wild type (WT) or
mutant CaM as presented in Fig. 1. Binding to the GST-7A-Cwild type protein
(top) and mutants relevant for C-lobe (middle) and N-lobe (bottom) interac-
tions is shown. Ca2 (300M)waspresent in all incubations. Note thatGST-7A
V867A still binds wild type CaM, but not CaM 1,2, whereas GST-7A F863A fails
to bind both proteins. GST-7A M872A increases, and M872E and R861P
decrease, binding to GFP-CaM 3,4. For further explanation, see text.
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critical hydrophobic residue Phe863. This substitution does not
impair in vitro binding to wild type CaM (12), but it could be
relevant for subtype-specific differences in the Ca2/CaM–
mediated regulation of group III mGluRs. The substitution
M872A increased CaM 1,2 binding, suggesting that introduc-
ing a smaller side chain facilitates other hydrophobic and
charge interactions. Consistent with this view, replacement of
Met872 by a larger, negatively charged residue (mutant M872E)
caused a highly significant reduction in bound Ca2/CaM.
Ionic interactions contribute importantly to Ca2/CaM
recruitment. Although positively charged amino acids preced-
ing CaM binding domains are known to aid in orienting the
binding helix on CaM by interacting with the negatively
charged rim of the C-lobe, residues of mixed charges also have
to be present on the N-lobe (50). Substitution of the positively
charged residue Arg859 by an oppositely charged glutamate
(R859E) was similar in its effect tomutation of the hydrophobic
residues Val866 and Val867, e.g. a loss of binding to CaM 1,2.
Replacement of Arg861 by an uncharged residue (R861P)
reduced binding to the N-lobe compared with M872A. How-
ever, introduction of a proline may disrupt the -helical struc-
ture of mGluR 7A-C, and the reduced binding thus may not
only reflect the loss of side-chain interactions. Here, we not
only identified the basic side chains ofmGluR 7A-C expected to
interact with the C-lobe (Gln857, Arg859, and Lys860), but we
also found a set of purely basic interactions between mGluR
7A-C (Lys858, Arg861, and Lys864) and the N-lobe of CaM (see
Fig. 5). In previous experiments (12), we had been unable to
dissect the contribution of the charged residues preceding the
CaM binding region when using wild type CaM, and hence we
concluded that the charged residues surrounding Phe863 are
not important for CaM binding. The data presented here con-
vincingly demonstrate that these charged residues are indeed
crucial. Their precise roles are presently unclear but could lie in
CaM binding prior to the Ca2-induced conformational
change of the N-lobe.
The modeling results discussed above suggest that CaM
bindingmight interfere with G binding via its N- and C-lobe
interaction with residues Lys858, Arg859, and, less importantly,
Gln857 of mGluR 7A-C (12). If only C-lobe activation were nec-
essary to displace G, modest changes in Ca2 levels should
be sufficient to cause displacement as compared with mecha-
nisms that require activation of the N-lobe of CaM, which has a
10-fold lower Ca2 binding affinity (54). Such N-lobe-depend-
ent regulation has been found for P/Q-type Ca2 channels (55),
which are downstream targets in the mGluR 7/G-pathway.
Thus, Ca2/CaM could differentially regulate mGluR 7 and
P/Q channels, because of differential C- or N-lobe activation in
response to local changes of Ca2. This may provide an eco-
nomic mechanism to temporally disperse different Ca2
effects. Our model also explains how phosphorylation of serine
862 may inhibit CaM binding by inter-atomic repulsion. Ser862
is phosphorylated by several protein kinase (PK) isoforms in
vitro, e.g. PKC (13, 24), PKA, and PKG (16). Activation of PKC
has been shown to reduce inhibition of glutamate release by
group III mGluRs at Schaffer collateral synapses in the CA1
region of the hippocampus (56). Notably, a GST-7A-C S862E
construct mimicking phosphorylation has been shown not to
bind Ca2/CaM, consistent with the approximate 1000-fold
reduction of Ser(P)862-mGluR 7A-(856–875) binding to CaM
in vitro and differences in electrostatic potential controlling
CaM binding (13).
In conclusion, our analysis of the structural determinants of
Ca2/CaM binding to mGluR 7A-C refines our understanding
of the mechanisms that control group III mGluR signaling via
competition of intracellular proteins for receptor-binding sites.
Our data are consistent with the proposal that these receptors
act as key regulatorymolecules in neurotransmitter release and
epileptogenesis (8). The intriguing question of how activity-de-
pendent changes in intracellular Ca2 levels may fine-tune
mGluR-mediated feedback inhibition is awaiting future struc-
tural and kinetic studies of C- and N-lobe binding to mGluR
7A-C. This is particularly important in face of the highly com-
partmentalized and very rapid kinetics of presynaptic Ca2
influx (52).
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